Effects of a pain oriented biobehavioral therapeutic education program on brain plasticity and pain intensity in subjects with chronic musculoskeletal pain: a feasibility study of a randomized controlled trial

BackgroundChronic pain significantly impacts the physical, emotional, and social wellbeing of individuals. Despite advances in treatments, chronic pain prevalence continues to rise, emphasizing the need for comprehensive therapeutic approaches.ObjectiveThis study aimed to evaluate the feasibility an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in neuroscience Ročník 19
Hlavní autoři: Di-Bonaventura, Silvia, Donado-Bermejo, Aser, Matesanz-García, Luis, Molina-Álvarez, Miguel, León-Hernández, José Vicente, Lizcano-Álvarez, Ángel, Lerma-Lara, Sergio, Nogales-Morales, Maximiliano, Molina, Nuria, Fernández-Carnero, Josué, Gurdiel-Álvarez, Francisco, Ferrer-Peña, Raúl
Médium: Journal Article
Jazyk:angličtina
Vydáno: Frontiers Media S.A 17.11.2025
Témata:
BDNF
brain plasticity
chronic pain
musculoskeletal pain
pain education
ISSN:1662-453X, 1662-453X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:BackgroundChronic pain significantly impacts the physical, emotional, and social wellbeing of individuals. Despite advances in treatments, chronic pain prevalence continues to rise, emphasizing the need for comprehensive therapeutic approaches.ObjectiveThis study aimed to evaluate the feasibility and preliminary effects of a one-month Pain Oriented Biobehavioral Therapeutic Education (POBTE) program on clinical outcomes for chronic primary musculoskeletal pain.MethodsIn a single-blind feasibility pilot of a randomized controlled trial, 16 participants were assigned to an intervention group receiving POBTE education and exercise (n = 8) or a control group (n = 8) participating in exercise only. Primary outcomes were pain intensity, measured by the Numeric Pain Rating Scale, and Brain-Derived Neurotrophic Factor (BDNF) plasma levels.ResultsThe intervention group showed a significant increase in BDNF levels from a mean of 2.174 at baseline to 3.063 at the end of treatment (p = 0.001, r = 0.63), with a non-significant reduction in pain intensity. Secondary outcomes, including anxiety, sleep quality, and physical activity, improved significantly. The results, however, should be interpreted cautiously due to the small sample size.ConclusionThe POBTE program appears feasible and acceptable, showing preliminary signals consistent with potential improvements in several clinical variables related to chronic pain management. These exploratory findings support the need for larger-scale, adequately powered trials.
ISSN:1662-453X
1662-453X
DOI:10.3389/fnins.2025.1664158